Herve Affagard is the founder of MaaT Pharma. MaaT Pharma has raised $141M in total funding. Latest round: IPO. Based in Paris, France.
Hervé Affagard is the Co-founder and CEO of MaaT Pharma, a clinical-stage biotechnology company focused on microbiome-based therapies for oncology and immune disorders. He has led the company for over 10 years, including its 2021 IPO on Euronext Paris.
Full founder directory · Investor directory · Company funding database · Fundraising library